NEW CASE STUDY Unlocking the power of process analytical technology to boost downstream operations    Dive in today!

AGC Biologics

1 min read

AGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine Candidate

Read press release